BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 9609979)

  • 1. Topical anthralin therapy for refractory nail psoriasis.
    Yamamoto T; Katayama I; Nishioka K
    J Dermatol; 1998 Apr; 25(4):231-3. PubMed ID: 9609979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center.
    Dutz JP; Lui H
    Int J Dermatol; 1998 Jan; 37(1):51-3. PubMed ID: 9522242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
    Yamamoto T; Nishioka K
    Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
    Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
    J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthralin cream as short contact therapy for psoriasis.
    Miller AC
    Cutis; 1985 Jun; 35(6):578-82. PubMed ID: 4017653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical anthralin for psoriasis vulgaris: evaluation of 70 Japanese patients.
    Yamamoto T; Matsuuchi M; Irimajiri J; Otoyama K; Nishioka K
    J Dermatol; 2000 Jul; 27(7):482-5. PubMed ID: 10935350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical calcipotriol therapy in nail psoriasis: a study of 24 cases.
    Zakeri M; Valikhani M; Mortazavi H; Barzegari M
    Dermatol Online J; 2005 Dec; 11(3):5. PubMed ID: 16409901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis.
    Anderson TF
    Med Clin North Am; 1982 Jul; 66(4):769-94. PubMed ID: 7047929
    [No Abstract]   [Full Text] [Related]  

  • 9. Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment.
    Sánchez Regaña M; Márquez Balbás G; Umbert Millet P
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):963-9. PubMed ID: 18410337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining lesional short-contact dithranol therapy of psoriasis with a potent topical corticosteroid.
    Swinkels OQ; Prins M; Kucharekova M; de Boo T; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
    Br J Dermatol; 2002 Apr; 146(4):621-6. PubMed ID: 11966693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Old wine in new bottles: the revival of anthralin.
    Harris DR
    Cutis; 1998 Oct; 62(4):201-3. PubMed ID: 9798112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin.
    Lowe NJ; Ashton RE; Koudsi H; Verschoore M; Schaefer H
    J Am Acad Dermatol; 1984 Jan; 10(1):69-72. PubMed ID: 6693604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of modified ingram therapy compared with severity of psoriasis.
    Youn JI; Kim BK; Suh DH
    J Dermatol; 1998 Feb; 25(2):112-7. PubMed ID: 9563279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anthralin therapy of psoriasis--a retrospective study of 39 cases].
    Higashi K; Katayama I; Nishioka K; Nishiyama S
    Nihon Hifuka Gakkai Zasshi; 1989 Feb; 99(2):129-34. PubMed ID: 2746967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-contact anthralin therapy for psoriasis using an aqueous cream formulation.
    Kingston TP; Lowe NJ; Whitefield M; Warin AP; Freeman K
    Cutis; 1987 Feb; 39(2):155-7. PubMed ID: 3829723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of a topical corticosteroid on short-contact high-dose dithranol therapy.
    Swinkels OQ; Prins M; Tosserams EF; Gerritsen MJ; Van Der Valk PG; Van De Kerkhof PC
    Br J Dermatol; 2001 Jul; 145(1):63-9. PubMed ID: 11453908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.
    Jiaravuthisan MM; Sasseville D; Vender RB; Murphy F; Muhn CY
    J Am Acad Dermatol; 2007 Jul; 57(1):1-27. PubMed ID: 17572277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of nail psoriasis with adalimumab: an open label unblinded study.
    Rigopoulos D; Gregoriou S; Lazaridou E; Belyayeva E; Apalla Z; Makris M; Katsambas A; Ioannides D
    J Eur Acad Dermatol Venereol; 2010 May; 24(5):530-4. PubMed ID: 19807825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment.
    Rigopoulos D; Gregoriou S; Daniel Iii CR; Belyayeva H; Larios G; Verra P; Stamou C; Kontochristopoulos G; Avgerinou G; Katsambas A
    Dermatology; 2009; 218(4):338-41. PubMed ID: 19212110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.